Pr MD - ALK Abell Sr Markets
| ALK-B Stock | DKK 158.50 3.80 2.46% |
Insider
Pr MD is Sr Markets of ALK Abell AS
| Phone | 45 45 74 75 76 |
| Web | https://www.alk.net |
ALK Abell Management Efficiency
The company has return on total asset (ROA) of 0.0516 % which means that it generated a profit of $0.0516 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0897 %, meaning that it generated $0.0897 on every $100 dollars invested by stockholders. ALK Abell's management efficiency ratios could be used to measure how well ALK Abell manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Birgitte Stephensen | Genmab AS | 59 | |
| Thomas Henriksen | Ambu AS | 50 | |
| Bassel Rifai | Ambu AS | N/A | |
| Nicolai Thomsen | Ambu AS | N/A | |
| Peter Gormsen | GN Store Nord | 49 | |
| Mns Barsne | Ambu AS | N/A | |
| Aurangzeb Khan | GN Store Nord | N/A | |
| Birgitte MSc | Genmab AS | 62 | |
| Michael Hjorth | NKT AS | 57 | |
| Judith MD | Genmab AS | 65 | |
| Peter Ros | Genmab AS | N/A | |
| Mikkel Wagner | Ambu AS | N/A | |
| Mijke Zachariasse | Genmab AS | 49 | |
| Cori Petersen | FLSmidth Co | 54 | |
| Kira Johnson | NKT AS | 49 | |
| Brian Pedersen | GN Store Nord | N/A | |
| Judith Klimovsky | Genmab AS | 63 | |
| Paolo Paoletti | Genmab AS | 68 | |
| Mikko Keto | FLSmidth Co | 56 | |
| Ehtisham Rabbani | GN Store Nord | N/A | |
| Thomas Schmidt | Ambu AS | 52 | |
Management Performance
| Return On Equity | 0.0897 | |||
| Return On Asset | 0.0516 |
ALK Abell AS Leadership Team
Elected by the shareholders, the ALK Abell's board of directors comprises two types of representatives: ALK Abell inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ALK. The board's role is to monitor ALK Abell's management team and ensure that shareholders' interests are well served. ALK Abell's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ALK Abell's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Soren Jelert, Ex CFO | ||
| Carsten Hellmann, CEO Pres | ||
| Miles Guralnick, Pres Inc | ||
| Sren Jelert, Ex CFO | ||
| Per Plotnikof, Investor Communications | ||
| Christian Houghton, Head Supply | ||
| Henrik Jacobi, Ex Management | ||
| Katja Thalund, Project Director | ||
| Pr MD, Sr Markets | ||
| Sren Niegel, Ex Board |
ALK Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ALK Abell a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0897 | |||
| Return On Asset | 0.0516 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.11 % | |||
| Current Valuation | 23.1 B | |||
| Shares Outstanding | 200.74 M | |||
| Shares Owned By Institutions | 61.95 % | |||
| Price To Earning | 214.15 X | |||
| Price To Book | 5.74 X | |||
| Price To Sales | 4.89 X |
Pair Trading with ALK Abell
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ALK Abell position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ALK Abell will appreciate offsetting losses from the drop in the long position's value.Moving together with ALK Stock
| 0.85 | NOVO-B | Novo Nordisk AS | PairCorr |
| 0.76 | GMAB | Genmab AS | PairCorr |
| 0.79 | BAVA | Bavarian Nordic | PairCorr |
| 0.7 | ZEAL | Zealand Pharma AS | PairCorr |
Moving against ALK Stock
The ability to find closely correlated positions to ALK Abell could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ALK Abell when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ALK Abell - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ALK Abell AS to buy it.
The correlation of ALK Abell is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ALK Abell moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ALK Abell AS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ALK Abell can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in ALK Stock
ALK Abell financial ratios help investors to determine whether ALK Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ALK with respect to the benefits of owning ALK Abell security.